CDMO Avid Bioservices Inc

Avid Bioservices Inc is engaged in development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture.

$29.53  -0.11 (-0.37%)
As of 10/27/2021 15:59:59 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  61,341,484
Average volume:  882,716
Market cap:   $1,818,161,586
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    05368M106
ISIN:        US05368M1062
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   286.08
PB ratio:   40.58
PS ratio:   17.96
Return on equity:   28.65%
Net income %:   12.63%